ArticleBiomedical reports2018

Canagliflozin improves obesity and insulin resistance in a diabetic patient with Cushings disease undergoing postoperative steroid therapy: A case report.

Kota Nishihama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.